What is CUSIP 89853L104?

CUSIP 89853L104 is the security identifier used in SEC filing datasets for TTOO - T2 BIOSYSTEMS INC - COM.

Who owns TTOO - T2 BIOSYSTEMS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Security Snapshot

T2 BIOSYSTEMS INC - COM (TTOO) Institutional Ownership

CUSIP: 89853L104

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / COM
Symbol: TTOO on Nasdaq

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Key facts

TTOO - T2 BIOSYSTEMS INC - COM is tracked under CUSIP 89853L104.
Latest finished 13F holder period is not available.
Schedule 13D/13G significant owner rows are not currently available.

Change

Holder count moved from 2 to 0 between Q4 2022 and Q1 2023.
Reported value moved from $109,000 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

89853L104

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

TTOO full holder history T2 Biosystems, Inc. SEC filings T2 Biosystems, Inc. company facts T2 Biosystems, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 89853L104:

Q1 2023 (0 holders) Q4 2022 (2 holders) Q3 2022 (52 holders) Q2 2022 (53 holders) Q1 2022 (62 holders) Q4 2021 (72 holders) Q3 2021 (75 holders) Q2 2021 (81 holders) Q1 2021 (78 holders) Q4 2020 (62 holders)

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

n/a

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2023 Q1	0	$0	-$58,000				0
2022 Q4	119,501	$109,000	-$2,772,580	$0	$0	$4.30	2
2022 Q3	24,648,910	$2,785,580	+$585,786	$7,000	$15,000	$0.11	52
2022 Q2	18,908,620	$3,053,292	+$496,520	$19,000	$21,000	$0.16	53
2022 Q1	15,112,162	$7,916,692	-$2,084,937	$71,000	$117,000	$0.52	62
2021 Q4	19,181,967	$9,901,613	-$2,401,321	$105,000	$135,000	$0.52	72
2021 Q3	23,022,826	$21,070,749	-$4,873,046	$292,000	$244,000	$0.92	75
2021 Q2	27,722,714	$32,970,597	+$1,356,481	$433,000	$320,000	$1.19	81
2021 Q1	26,277,491	$42,549,392	+$8,213,142	$821,000	$626,000	$1.62	78
2020 Q4	21,270,341	$26,396,976	+$3,692,339	$135,000	$185,000	$1.24	62
2020 Q3	18,243,518	$24,802,168	+$4,519,431	$269,000	$84,000	$1.36	56
2020 Q2	14,877,864	$18,905,027	+$4,694,736	$146,000	$166,000	$1.27	47
2020 Q1	11,375,622	$7,380,419	-$5,509	$42,000	$7,000	$0.65	41
2019 Q4	10,910,887	$12,763,062	-$1,205,019	$59,000	$28,000	$1.17	47
2019 Q3	11,025,045	$27,563,970	-$10,645,069	$131,000	$263,000	$2.50	52
2019 Q2	17,044,773	$28,551,716	-$7,201,699	$165,000	$158,000	$1.68	66
2019 Q1	20,470,077	$53,833,432	-$4,658,311	$419,000	$220,000	$2.63	76
2018 Q4	21,938,282	$66,034,109	-$11,263,105	$193,000	$175,000	$3.01	91
2018 Q3	24,254,632	$180,713,228	-$15,615,363	$945,000	$798,000	$7.45	96
2018 Q2	26,267,127	$203,286,819	+$57,502,545	$1,220,000	$1,602,000	$7.74	100
2018 Q1	18,951,936	$122,993,013	+$21,930	$342,000	$390,000	$6.49	54
2017 Q4	19,001,116	$78,280,008	-$2,359,666	$57,000	$281,000	$4.12	44
2017 Q3	21,518,508	$82,191,201	+$13,982,459	$49,000		$4.20	41
2017 Q2	18,628,129	$53,538,267	-$8,465,235	$0		$3.21	39
2017 Q1	20,332,506	$106,949,405	+$2,766,424	$54,000	$0	$5.26	45
2016 Q4	20,558,927	$108,140,050	-$1,766,947	$159,000	$155,000	$5.26	51
2016 Q3	20,870,697	$151,094,839	-$1,557,707	$219,000	$260,000	$7.24	50
2016 Q2	18,851,831	$148,740,561	+$7,003,888		$84,000	$7.89	56
2016 Q1	18,590,284	$183,292,000	+$4,239,145			$9.86	55
2015 Q4	17,371,988	$190,048,787	+$36,795,020			$10.94	61
2015 Q3	14,015,351	$122,775,460	-$3,878,117			$8.76	51
2015 Q2	11,421,234	$185,364,727	+$998,757			$16.23	57
2015 Q1	11,380,711	$176,625,729	+$16,838,095			$15.52	52
2014 Q4	10,224,536	$196,715,342	+$265,419			$19.24	42
2014 Q3	9,985,277	$180,634,000	+$180,623,000			$18.09	40